nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—EDNRA—atherosclerosis	0.466	1	CbGaD
Bosentan—ABCB11—Rosuvastatin—atherosclerosis	0.118	0.327	CbGbCtD
Bosentan—ABCB11—Pravastatin—atherosclerosis	0.108	0.297	CbGbCtD
Bosentan—CYP2C9—Rosuvastatin—atherosclerosis	0.0209	0.0577	CbGbCtD
Bosentan—CYP2C9—Simvastatin—atherosclerosis	0.0195	0.0537	CbGbCtD
Bosentan—CYP2C9—Pravastatin—atherosclerosis	0.019	0.0525	CbGbCtD
Bosentan—CYP2C9—Lovastatin—atherosclerosis	0.019	0.0525	CbGbCtD
Bosentan—CYP3A4—Rosuvastatin—atherosclerosis	0.0122	0.0336	CbGbCtD
Bosentan—CYP3A4—Ezetimibe—atherosclerosis	0.0122	0.0336	CbGbCtD
Bosentan—CYP3A4—Simvastatin—atherosclerosis	0.0113	0.0312	CbGbCtD
Bosentan—CYP3A4—Lovastatin—atherosclerosis	0.0111	0.0305	CbGbCtD
Bosentan—CYP3A4—Pravastatin—atherosclerosis	0.0111	0.0305	CbGbCtD
Bosentan—Flatulence—Lovastatin—atherosclerosis	0.000251	0.00246	CcSEcCtD
Bosentan—Hypoaesthesia—Niacin—atherosclerosis	0.00025	0.00245	CcSEcCtD
Bosentan—Malnutrition—Ezetimibe—atherosclerosis	0.00025	0.00245	CcSEcCtD
Bosentan—Erythema—Ezetimibe—atherosclerosis	0.00025	0.00245	CcSEcCtD
Bosentan—Oedema peripheral—Niacin—atherosclerosis	0.000247	0.00242	CcSEcCtD
Bosentan—Hepatitis—Pravastatin—atherosclerosis	0.000247	0.00242	CcSEcCtD
Bosentan—Back pain—Lovastatin—atherosclerosis	0.000246	0.00241	CcSEcCtD
Bosentan—Hypoaesthesia—Pravastatin—atherosclerosis	0.000246	0.00241	CcSEcCtD
Bosentan—Flatulence—Ezetimibe—atherosclerosis	0.000246	0.00241	CcSEcCtD
Bosentan—Chills—Simvastatin—atherosclerosis	0.000245	0.00241	CcSEcCtD
Bosentan—Muscle spasms—Lovastatin—atherosclerosis	0.000245	0.0024	CcSEcCtD
Bosentan—Infection—Rosuvastatin—atherosclerosis	0.000243	0.00239	CcSEcCtD
Bosentan—Back pain—Ezetimibe—atherosclerosis	0.000241	0.00237	CcSEcCtD
Bosentan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00024	0.00236	CcSEcCtD
Bosentan—Muscle spasms—Ezetimibe—atherosclerosis	0.00024	0.00235	CcSEcCtD
Bosentan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00024	0.00235	CcSEcCtD
Bosentan—Vision blurred—Lovastatin—atherosclerosis	0.00024	0.00235	CcSEcCtD
Bosentan—Mental disorder—Simvastatin—atherosclerosis	0.00024	0.00235	CcSEcCtD
Bosentan—Tremor—Lovastatin—atherosclerosis	0.000238	0.00234	CcSEcCtD
Bosentan—Erythema—Simvastatin—atherosclerosis	0.000238	0.00233	CcSEcCtD
Bosentan—Eye disorder—Niacin—atherosclerosis	0.000235	0.0023	CcSEcCtD
Bosentan—Flatulence—Simvastatin—atherosclerosis	0.000235	0.0023	CcSEcCtD
Bosentan—Tinnitus—Niacin—atherosclerosis	0.000234	0.00229	CcSEcCtD
Bosentan—Erythema multiforme—Pravastatin—atherosclerosis	0.000234	0.00229	CcSEcCtD
Bosentan—Flushing—Niacin—atherosclerosis	0.000233	0.00228	CcSEcCtD
Bosentan—Angioedema—Lovastatin—atherosclerosis	0.000232	0.00228	CcSEcCtD
Bosentan—Anaemia—Ezetimibe—atherosclerosis	0.000231	0.00226	CcSEcCtD
Bosentan—Tinnitus—Pravastatin—atherosclerosis	0.00023	0.00226	CcSEcCtD
Bosentan—Cardiac disorder—Pravastatin—atherosclerosis	0.000229	0.00225	CcSEcCtD
Bosentan—Flushing—Pravastatin—atherosclerosis	0.000229	0.00225	CcSEcCtD
Bosentan—Muscle spasms—Simvastatin—atherosclerosis	0.000229	0.00224	CcSEcCtD
Bosentan—Vertigo—Lovastatin—atherosclerosis	0.000229	0.00224	CcSEcCtD
Bosentan—Angioedema—Ezetimibe—atherosclerosis	0.000228	0.00224	CcSEcCtD
Bosentan—Angiopathy—Niacin—atherosclerosis	0.000228	0.00223	CcSEcCtD
Bosentan—Leukopenia—Lovastatin—atherosclerosis	0.000228	0.00223	CcSEcCtD
Bosentan—Chills—Niacin—atherosclerosis	0.000225	0.00221	CcSEcCtD
Bosentan—Vision blurred—Simvastatin—atherosclerosis	0.000224	0.0022	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000223	0.00219	CcSEcCtD
Bosentan—Tremor—Simvastatin—atherosclerosis	0.000223	0.00219	CcSEcCtD
Bosentan—Chills—Pravastatin—atherosclerosis	0.000222	0.00217	CcSEcCtD
Bosentan—Insomnia—Rosuvastatin—atherosclerosis	0.000222	0.00217	CcSEcCtD
Bosentan—Palpitations—Ezetimibe—atherosclerosis	0.000221	0.00216	CcSEcCtD
Bosentan—Paraesthesia—Rosuvastatin—atherosclerosis	0.00022	0.00216	CcSEcCtD
Bosentan—Anaemia—Simvastatin—atherosclerosis	0.00022	0.00216	CcSEcCtD
Bosentan—Malnutrition—Niacin—atherosclerosis	0.000219	0.00214	CcSEcCtD
Bosentan—Erythema—Niacin—atherosclerosis	0.000219	0.00214	CcSEcCtD
Bosentan—Cough—Ezetimibe—atherosclerosis	0.000218	0.00214	CcSEcCtD
Bosentan—Angioedema—Simvastatin—atherosclerosis	0.000217	0.00213	CcSEcCtD
Bosentan—Arthralgia—Lovastatin—atherosclerosis	0.000217	0.00212	CcSEcCtD
Bosentan—Chest pain—Lovastatin—atherosclerosis	0.000217	0.00212	CcSEcCtD
Bosentan—Anxiety—Lovastatin—atherosclerosis	0.000216	0.00212	CcSEcCtD
Bosentan—Dyspepsia—Rosuvastatin—atherosclerosis	0.000216	0.00211	CcSEcCtD
Bosentan—Flatulence—Niacin—atherosclerosis	0.000215	0.00211	CcSEcCtD
Bosentan—Discomfort—Lovastatin—atherosclerosis	0.000214	0.0021	CcSEcCtD
Bosentan—Vertigo—Simvastatin—atherosclerosis	0.000214	0.0021	CcSEcCtD
Bosentan—Leukopenia—Simvastatin—atherosclerosis	0.000213	0.00209	CcSEcCtD
Bosentan—Chest pain—Ezetimibe—atherosclerosis	0.000212	0.00208	CcSEcCtD
Bosentan—Arthralgia—Ezetimibe—atherosclerosis	0.000212	0.00208	CcSEcCtD
Bosentan—Flatulence—Pravastatin—atherosclerosis	0.000212	0.00208	CcSEcCtD
Bosentan—Dry mouth—Lovastatin—atherosclerosis	0.000212	0.00208	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000211	0.00207	CcSEcCtD
Bosentan—Muscle spasms—Niacin—atherosclerosis	0.00021	0.00206	CcSEcCtD
Bosentan—Discomfort—Ezetimibe—atherosclerosis	0.00021	0.00206	CcSEcCtD
Bosentan—Constipation—Rosuvastatin—atherosclerosis	0.00021	0.00205	CcSEcCtD
Bosentan—Pain—Rosuvastatin—atherosclerosis	0.00021	0.00205	CcSEcCtD
Bosentan—Dry mouth—Ezetimibe—atherosclerosis	0.000208	0.00204	CcSEcCtD
Bosentan—Anaphylactic shock—Lovastatin—atherosclerosis	0.000208	0.00204	CcSEcCtD
Bosentan—Muscle spasms—Pravastatin—atherosclerosis	0.000207	0.00203	CcSEcCtD
Bosentan—Infection—Lovastatin—atherosclerosis	0.000206	0.00202	CcSEcCtD
Bosentan—Vision blurred—Niacin—atherosclerosis	0.000206	0.00202	CcSEcCtD
Bosentan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000204	0.002	CcSEcCtD
Bosentan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000203	0.00199	CcSEcCtD
Bosentan—Vision blurred—Pravastatin—atherosclerosis	0.000203	0.00199	CcSEcCtD
Bosentan—Arthralgia—Simvastatin—atherosclerosis	0.000203	0.00199	CcSEcCtD
Bosentan—Chest pain—Simvastatin—atherosclerosis	0.000203	0.00199	CcSEcCtD
Bosentan—Infection—Ezetimibe—atherosclerosis	0.000202	0.00198	CcSEcCtD
Bosentan—Anxiety—Simvastatin—atherosclerosis	0.000202	0.00198	CcSEcCtD
Bosentan—Tremor—Pravastatin—atherosclerosis	0.000202	0.00198	CcSEcCtD
Bosentan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.0002	0.00196	CcSEcCtD
Bosentan—Discomfort—Simvastatin—atherosclerosis	0.0002	0.00196	CcSEcCtD
Bosentan—Nervous system disorder—Ezetimibe—atherosclerosis	0.0002	0.00196	CcSEcCtD
Bosentan—Angioedema—Niacin—atherosclerosis	0.0002	0.00196	CcSEcCtD
Bosentan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000199	0.00196	CcSEcCtD
Bosentan—Anaemia—Pravastatin—atherosclerosis	0.000199	0.00195	CcSEcCtD
Bosentan—Anorexia—Lovastatin—atherosclerosis	0.000198	0.00194	CcSEcCtD
Bosentan—Skin disorder—Ezetimibe—atherosclerosis	0.000198	0.00194	CcSEcCtD
Bosentan—Angioedema—Pravastatin—atherosclerosis	0.000197	0.00193	CcSEcCtD
Bosentan—Vertigo—Niacin—atherosclerosis	0.000196	0.00192	CcSEcCtD
Bosentan—Syncope—Niacin—atherosclerosis	0.000196	0.00192	CcSEcCtD
Bosentan—Leukopenia—Niacin—atherosclerosis	0.000196	0.00192	CcSEcCtD
Bosentan—Urticaria—Rosuvastatin—atherosclerosis	0.000195	0.00191	CcSEcCtD
Bosentan—Anaphylactic shock—Simvastatin—atherosclerosis	0.000194	0.0019	CcSEcCtD
Bosentan—Oedema—Simvastatin—atherosclerosis	0.000194	0.0019	CcSEcCtD
Bosentan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000194	0.0019	CcSEcCtD
Bosentan—Vertigo—Pravastatin—atherosclerosis	0.000193	0.0019	CcSEcCtD
Bosentan—Palpitations—Niacin—atherosclerosis	0.000193	0.00189	CcSEcCtD
Bosentan—Infection—Simvastatin—atherosclerosis	0.000193	0.00189	CcSEcCtD
Bosentan—Leukopenia—Pravastatin—atherosclerosis	0.000193	0.00189	CcSEcCtD
Bosentan—Loss of consciousness—Niacin—atherosclerosis	0.000192	0.00188	CcSEcCtD
Bosentan—Cough—Niacin—atherosclerosis	0.000191	0.00187	CcSEcCtD
Bosentan—Thrombocytopenia—Simvastatin—atherosclerosis	0.00019	0.00186	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000189	0.00185	CcSEcCtD
Bosentan—Insomnia—Lovastatin—atherosclerosis	0.000188	0.00184	CcSEcCtD
Bosentan—Cough—Pravastatin—atherosclerosis	0.000188	0.00184	CcSEcCtD
Bosentan—Paraesthesia—Lovastatin—atherosclerosis	0.000186	0.00183	CcSEcCtD
Bosentan—Arthralgia—Niacin—atherosclerosis	0.000186	0.00182	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000186	0.00182	CcSEcCtD
Bosentan—Anorexia—Simvastatin—atherosclerosis	0.000185	0.00182	CcSEcCtD
Bosentan—Dyspnoea—Lovastatin—atherosclerosis	0.000185	0.00182	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000185	0.00181	CcSEcCtD
Bosentan—Insomnia—Ezetimibe—atherosclerosis	0.000184	0.00181	CcSEcCtD
Bosentan—Chest pain—Pravastatin—atherosclerosis	0.000183	0.0018	CcSEcCtD
Bosentan—Arthralgia—Pravastatin—atherosclerosis	0.000183	0.0018	CcSEcCtD
Bosentan—Paraesthesia—Ezetimibe—atherosclerosis	0.000183	0.00179	CcSEcCtD
Bosentan—Dyspepsia—Lovastatin—atherosclerosis	0.000183	0.00179	CcSEcCtD
Bosentan—Anxiety—Pravastatin—atherosclerosis	0.000183	0.00179	CcSEcCtD
Bosentan—Dry mouth—Niacin—atherosclerosis	0.000182	0.00178	CcSEcCtD
Bosentan—Dyspnoea—Ezetimibe—atherosclerosis	0.000182	0.00178	CcSEcCtD
Bosentan—Discomfort—Pravastatin—atherosclerosis	0.000181	0.00177	CcSEcCtD
Bosentan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000181	0.00177	CcSEcCtD
Bosentan—Decreased appetite—Lovastatin—atherosclerosis	0.000181	0.00177	CcSEcCtD
Bosentan—Dyspepsia—Ezetimibe—atherosclerosis	0.000179	0.00176	CcSEcCtD
Bosentan—Fatigue—Lovastatin—atherosclerosis	0.000179	0.00176	CcSEcCtD
Bosentan—Anaphylactic shock—Niacin—atherosclerosis	0.000178	0.00175	CcSEcCtD
Bosentan—Oedema—Niacin—atherosclerosis	0.000178	0.00175	CcSEcCtD
Bosentan—Pain—Lovastatin—atherosclerosis	0.000178	0.00174	CcSEcCtD
Bosentan—Constipation—Lovastatin—atherosclerosis	0.000178	0.00174	CcSEcCtD
Bosentan—Decreased appetite—Ezetimibe—atherosclerosis	0.000177	0.00174	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000177	0.00173	CcSEcCtD
Bosentan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Asthenia—Rosuvastatin—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Insomnia—Simvastatin—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Anaphylactic shock—Pravastatin—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Oedema—Pravastatin—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Fatigue—Ezetimibe—atherosclerosis	0.000176	0.00172	CcSEcCtD
Bosentan—Shock—Niacin—atherosclerosis	0.000175	0.00172	CcSEcCtD
Bosentan—Infection—Pravastatin—atherosclerosis	0.000174	0.00171	CcSEcCtD
Bosentan—Paraesthesia—Simvastatin—atherosclerosis	0.000174	0.00171	CcSEcCtD
Bosentan—Pain—Ezetimibe—atherosclerosis	0.000174	0.00171	CcSEcCtD
Bosentan—Constipation—Ezetimibe—atherosclerosis	0.000174	0.00171	CcSEcCtD
Bosentan—Tachycardia—Niacin—atherosclerosis	0.000174	0.00171	CcSEcCtD
Bosentan—Pruritus—Rosuvastatin—atherosclerosis	0.000173	0.0017	CcSEcCtD
Bosentan—Skin disorder—Niacin—atherosclerosis	0.000173	0.0017	CcSEcCtD
Bosentan—Dyspnoea—Simvastatin—atherosclerosis	0.000173	0.0017	CcSEcCtD
Bosentan—Hyperhidrosis—Niacin—atherosclerosis	0.000172	0.00169	CcSEcCtD
Bosentan—Thrombocytopenia—Pravastatin—atherosclerosis	0.000172	0.00169	CcSEcCtD
Bosentan—Dyspepsia—Simvastatin—atherosclerosis	0.000171	0.00168	CcSEcCtD
Bosentan—Anorexia—Niacin—atherosclerosis	0.00017	0.00167	CcSEcCtD
Bosentan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00017	0.00166	CcSEcCtD
Bosentan—Hyperhidrosis—Pravastatin—atherosclerosis	0.00017	0.00166	CcSEcCtD
Bosentan—Decreased appetite—Simvastatin—atherosclerosis	0.000169	0.00166	CcSEcCtD
Bosentan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000168	0.00164	CcSEcCtD
Bosentan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000168	0.00164	CcSEcCtD
Bosentan—Fatigue—Simvastatin—atherosclerosis	0.000167	0.00164	CcSEcCtD
Bosentan—Anorexia—Pravastatin—atherosclerosis	0.000167	0.00164	CcSEcCtD
Bosentan—Hypotension—Niacin—atherosclerosis	0.000167	0.00163	CcSEcCtD
Bosentan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000167	0.00163	CcSEcCtD
Bosentan—Pain—Simvastatin—atherosclerosis	0.000166	0.00163	CcSEcCtD
Bosentan—Constipation—Simvastatin—atherosclerosis	0.000166	0.00163	CcSEcCtD
Bosentan—Urticaria—Lovastatin—atherosclerosis	0.000165	0.00162	CcSEcCtD
Bosentan—Body temperature increased—Lovastatin—atherosclerosis	0.000164	0.00161	CcSEcCtD
Bosentan—Abdominal pain—Lovastatin—atherosclerosis	0.000164	0.00161	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000162	0.00159	CcSEcCtD
Bosentan—Dizziness—Rosuvastatin—atherosclerosis	0.000162	0.00159	CcSEcCtD
Bosentan—Urticaria—Ezetimibe—atherosclerosis	0.000162	0.00159	CcSEcCtD
Bosentan—Insomnia—Niacin—atherosclerosis	0.000161	0.00158	CcSEcCtD
Bosentan—Abdominal pain—Ezetimibe—atherosclerosis	0.000161	0.00158	CcSEcCtD
Bosentan—Body temperature increased—Ezetimibe—atherosclerosis	0.000161	0.00158	CcSEcCtD
Bosentan—Paraesthesia—Niacin—atherosclerosis	0.00016	0.00157	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00016	0.00157	CcSEcCtD
Bosentan—Dyspnoea—Niacin—atherosclerosis	0.000159	0.00156	CcSEcCtD
Bosentan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000159	0.00156	CcSEcCtD
Bosentan—Insomnia—Pravastatin—atherosclerosis	0.000159	0.00156	CcSEcCtD
Bosentan—Somnolence—Niacin—atherosclerosis	0.000159	0.00155	CcSEcCtD
Bosentan—Paraesthesia—Pravastatin—atherosclerosis	0.000158	0.00155	CcSEcCtD
Bosentan—Dyspepsia—Niacin—atherosclerosis	0.000157	0.00154	CcSEcCtD
Bosentan—Dyspnoea—Pravastatin—atherosclerosis	0.000157	0.00153	CcSEcCtD
Bosentan—Decreased appetite—Niacin—atherosclerosis	0.000155	0.00152	CcSEcCtD
Bosentan—Dyspepsia—Pravastatin—atherosclerosis	0.000155	0.00152	CcSEcCtD
Bosentan—Rash—Rosuvastatin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Dermatitis—Rosuvastatin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Urticaria—Simvastatin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Gastrointestinal disorder—Niacin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Abdominal pain—Simvastatin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Body temperature increased—Simvastatin—atherosclerosis	0.000154	0.00151	CcSEcCtD
Bosentan—Headache—Rosuvastatin—atherosclerosis	0.000153	0.00151	CcSEcCtD
Bosentan—Hypersensitivity—Lovastatin—atherosclerosis	0.000153	0.0015	CcSEcCtD
Bosentan—Decreased appetite—Pravastatin—atherosclerosis	0.000153	0.0015	CcSEcCtD
Bosentan—Pain—Niacin—atherosclerosis	0.000153	0.0015	CcSEcCtD
Bosentan—Fatigue—Pravastatin—atherosclerosis	0.000151	0.00148	CcSEcCtD
Bosentan—Pain—Pravastatin—atherosclerosis	0.00015	0.00147	CcSEcCtD
Bosentan—Constipation—Pravastatin—atherosclerosis	0.00015	0.00147	CcSEcCtD
Bosentan—Hypersensitivity—Ezetimibe—atherosclerosis	0.00015	0.00147	CcSEcCtD
Bosentan—Asthenia—Lovastatin—atherosclerosis	0.000149	0.00146	CcSEcCtD
Bosentan—Pruritus—Lovastatin—atherosclerosis	0.000147	0.00144	CcSEcCtD
Bosentan—Asthenia—Ezetimibe—atherosclerosis	0.000146	0.00143	CcSEcCtD
Bosentan—Gastrointestinal pain—Niacin—atherosclerosis	0.000146	0.00143	CcSEcCtD
Bosentan—Nausea—Rosuvastatin—atherosclerosis	0.000146	0.00143	CcSEcCtD
Bosentan—Pruritus—Ezetimibe—atherosclerosis	0.000144	0.00141	CcSEcCtD
Bosentan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000144	0.00141	CcSEcCtD
Bosentan—Hypersensitivity—Simvastatin—atherosclerosis	0.000143	0.0014	CcSEcCtD
Bosentan—Diarrhoea—Lovastatin—atherosclerosis	0.000142	0.00139	CcSEcCtD
Bosentan—Urticaria—Niacin—atherosclerosis	0.000142	0.00139	CcSEcCtD
Bosentan—Abdominal pain—Niacin—atherosclerosis	0.000141	0.00138	CcSEcCtD
Bosentan—Body temperature increased—Niacin—atherosclerosis	0.000141	0.00138	CcSEcCtD
Bosentan—Urticaria—Pravastatin—atherosclerosis	0.000139	0.00137	CcSEcCtD
Bosentan—Asthenia—Simvastatin—atherosclerosis	0.000139	0.00137	CcSEcCtD
Bosentan—Diarrhoea—Ezetimibe—atherosclerosis	0.000139	0.00137	CcSEcCtD
Bosentan—Body temperature increased—Pravastatin—atherosclerosis	0.000139	0.00136	CcSEcCtD
Bosentan—Abdominal pain—Pravastatin—atherosclerosis	0.000139	0.00136	CcSEcCtD
Bosentan—Pruritus—Simvastatin—atherosclerosis	0.000137	0.00135	CcSEcCtD
Bosentan—Dizziness—Lovastatin—atherosclerosis	0.000137	0.00135	CcSEcCtD
Bosentan—Dizziness—Ezetimibe—atherosclerosis	0.000135	0.00132	CcSEcCtD
Bosentan—Diarrhoea—Simvastatin—atherosclerosis	0.000133	0.0013	CcSEcCtD
Bosentan—Vomiting—Lovastatin—atherosclerosis	0.000132	0.00129	CcSEcCtD
Bosentan—Hypersensitivity—Niacin—atherosclerosis	0.000131	0.00129	CcSEcCtD
Bosentan—Rash—Lovastatin—atherosclerosis	0.000131	0.00128	CcSEcCtD
Bosentan—Dermatitis—Lovastatin—atherosclerosis	0.000131	0.00128	CcSEcCtD
Bosentan—Headache—Lovastatin—atherosclerosis	0.00013	0.00128	CcSEcCtD
Bosentan—Vomiting—Ezetimibe—atherosclerosis	0.000129	0.00127	CcSEcCtD
Bosentan—Hypersensitivity—Pravastatin—atherosclerosis	0.000129	0.00127	CcSEcCtD
Bosentan—Dizziness—Simvastatin—atherosclerosis	0.000128	0.00126	CcSEcCtD
Bosentan—Rash—Ezetimibe—atherosclerosis	0.000128	0.00126	CcSEcCtD
Bosentan—Dermatitis—Ezetimibe—atherosclerosis	0.000128	0.00126	CcSEcCtD
Bosentan—Asthenia—Niacin—atherosclerosis	0.000128	0.00125	CcSEcCtD
Bosentan—Headache—Ezetimibe—atherosclerosis	0.000128	0.00125	CcSEcCtD
Bosentan—Pruritus—Niacin—atherosclerosis	0.000126	0.00124	CcSEcCtD
Bosentan—Asthenia—Pravastatin—atherosclerosis	0.000126	0.00124	CcSEcCtD
Bosentan—Pruritus—Pravastatin—atherosclerosis	0.000124	0.00122	CcSEcCtD
Bosentan—Vomiting—Simvastatin—atherosclerosis	0.000123	0.00121	CcSEcCtD
Bosentan—Nausea—Lovastatin—atherosclerosis	0.000123	0.00121	CcSEcCtD
Bosentan—Rash—Simvastatin—atherosclerosis	0.000122	0.0012	CcSEcCtD
Bosentan—Dermatitis—Simvastatin—atherosclerosis	0.000122	0.0012	CcSEcCtD
Bosentan—Diarrhoea—Niacin—atherosclerosis	0.000122	0.0012	CcSEcCtD
Bosentan—Headache—Simvastatin—atherosclerosis	0.000122	0.00119	CcSEcCtD
Bosentan—Nausea—Ezetimibe—atherosclerosis	0.000121	0.00119	CcSEcCtD
Bosentan—Diarrhoea—Pravastatin—atherosclerosis	0.00012	0.00118	CcSEcCtD
Bosentan—Dizziness—Niacin—atherosclerosis	0.000118	0.00116	CcSEcCtD
Bosentan—Dizziness—Pravastatin—atherosclerosis	0.000116	0.00114	CcSEcCtD
Bosentan—Nausea—Simvastatin—atherosclerosis	0.000115	0.00113	CcSEcCtD
Bosentan—Vomiting—Niacin—atherosclerosis	0.000113	0.00111	CcSEcCtD
Bosentan—Rash—Niacin—atherosclerosis	0.000112	0.0011	CcSEcCtD
Bosentan—Dermatitis—Niacin—atherosclerosis	0.000112	0.0011	CcSEcCtD
Bosentan—Headache—Niacin—atherosclerosis	0.000112	0.0011	CcSEcCtD
Bosentan—Vomiting—Pravastatin—atherosclerosis	0.000112	0.00109	CcSEcCtD
Bosentan—Rash—Pravastatin—atherosclerosis	0.000111	0.00109	CcSEcCtD
Bosentan—Dermatitis—Pravastatin—atherosclerosis	0.000111	0.00108	CcSEcCtD
Bosentan—Headache—Pravastatin—atherosclerosis	0.00011	0.00108	CcSEcCtD
Bosentan—Nausea—Niacin—atherosclerosis	0.000106	0.00104	CcSEcCtD
Bosentan—Nausea—Pravastatin—atherosclerosis	0.000104	0.00102	CcSEcCtD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.65e-05	0.00038	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—CXCL8—atherosclerosis	2.65e-05	0.000379	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.65e-05	0.000379	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AGT—atherosclerosis	2.64e-05	0.000379	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—EDN1—atherosclerosis	2.63e-05	0.000377	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.62e-05	0.000376	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.62e-05	0.000375	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCR2—atherosclerosis	2.61e-05	0.000374	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL5—atherosclerosis	2.61e-05	0.000374	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	2.6e-05	0.000373	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CYBA—atherosclerosis	2.6e-05	0.000372	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALOX5—atherosclerosis	2.59e-05	0.000371	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—PIK3CG—atherosclerosis	2.57e-05	0.000369	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LPL—atherosclerosis	2.55e-05	0.000365	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLAT—atherosclerosis	2.54e-05	0.000364	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—GHRL—atherosclerosis	2.54e-05	0.000364	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PARP1—atherosclerosis	2.54e-05	0.000364	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PRKCG—atherosclerosis	2.48e-05	0.000355	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—F2—atherosclerosis	2.44e-05	0.00035	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SPP1—atherosclerosis	2.41e-05	0.000346	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.4e-05	0.000345	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—CXCL8—atherosclerosis	2.4e-05	0.000345	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.39e-05	0.000342	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—PIK3CG—atherosclerosis	2.34e-05	0.000335	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NAMPT—atherosclerosis	2.32e-05	0.000332	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.31e-05	0.00033	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LIPC—atherosclerosis	2.3e-05	0.00033	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOC3—atherosclerosis	2.29e-05	0.000328	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.28e-05	0.000327	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.28e-05	0.000327	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.28e-05	0.000327	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.28e-05	0.000327	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LDLR—atherosclerosis	2.28e-05	0.000326	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	2.25e-05	0.000323	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PDGFB—atherosclerosis	2.23e-05	0.00032	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—KNG1—atherosclerosis	2.23e-05	0.00032	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CETP—atherosclerosis	2.22e-05	0.000319	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGTR1—atherosclerosis	2.22e-05	0.000318	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AGT—atherosclerosis	2.18e-05	0.000313	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CCL2—atherosclerosis	2.18e-05	0.000312	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	2.17e-05	0.000312	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PLG—atherosclerosis	2.16e-05	0.00031	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—LEP—atherosclerosis	2.14e-05	0.000306	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOE—atherosclerosis	2.14e-05	0.000306	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—SCARB1—atherosclerosis	2.13e-05	0.000305	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CAV1—atherosclerosis	2.12e-05	0.000304	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—APOA1—atherosclerosis	2.11e-05	0.000303	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	2.08e-05	0.000299	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.07e-05	0.000297	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SOCS3—atherosclerosis	2.05e-05	0.000293	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—ESR1—atherosclerosis	2.04e-05	0.000292	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—F2—atherosclerosis	2.02e-05	0.000289	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMGCR—atherosclerosis	2.01e-05	0.000288	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	2.01e-05	0.000288	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	1.98e-05	0.000284	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP3—atherosclerosis	1.98e-05	0.000283	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF2—atherosclerosis	1.97e-05	0.000282	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.94e-05	0.000278	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—PIK3CG—atherosclerosis	1.93e-05	0.000276	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOB—atherosclerosis	1.91e-05	0.000274	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—CXCL8—atherosclerosis	1.89e-05	0.000272	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—EDN1—atherosclerosis	1.88e-05	0.00027	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL5—atherosclerosis	1.87e-05	0.000267	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLTP—atherosclerosis	1.86e-05	0.000267	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—MAPK3—atherosclerosis	1.85e-05	0.000265	CbGpPWpGaD
Bosentan—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.84e-05	0.000264	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—INS—atherosclerosis	1.83e-05	0.000262	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LPL—atherosclerosis	1.82e-05	0.000262	CbGpPWpGaD
Bosentan—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.82e-05	0.000261	CbGpPWpGaD
Bosentan—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.81e-05	0.00026	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CCL2—atherosclerosis	1.8e-05	0.000257	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ABCA1—atherosclerosis	1.79e-05	0.000257	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PRKCG—atherosclerosis	1.77e-05	0.000254	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IGF1—atherosclerosis	1.77e-05	0.000253	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SPP1—atherosclerosis	1.73e-05	0.000248	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.73e-05	0.000248	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—CXCL8—atherosclerosis	1.72e-05	0.000247	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.72e-05	0.000246	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.71e-05	0.000245	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—SERPINE1—atherosclerosis	1.68e-05	0.00024	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.67e-05	0.000239	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.62e-05	0.000232	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.62e-05	0.000232	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NOS3—atherosclerosis	1.6e-05	0.00023	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PDGFB—atherosclerosis	1.6e-05	0.000229	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.6e-05	0.000229	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AGT—atherosclerosis	1.56e-05	0.000224	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—HMOX1—atherosclerosis	1.54e-05	0.00022	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—LEP—atherosclerosis	1.53e-05	0.000219	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOE—atherosclerosis	1.53e-05	0.000219	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CAV1—atherosclerosis	1.52e-05	0.000217	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—APOA1—atherosclerosis	1.51e-05	0.000217	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.51e-05	0.000216	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOB—atherosclerosis	1.47e-05	0.000211	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—ESR1—atherosclerosis	1.46e-05	0.000209	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—F2—atherosclerosis	1.44e-05	0.000207	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GSTM1—atherosclerosis	1.43e-05	0.000205	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—CXCL8—atherosclerosis	1.42e-05	0.000204	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—LPL—atherosclerosis	1.41e-05	0.000202	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—PIK3CG—atherosclerosis	1.38e-05	0.000198	CbGpPWpGaD
Bosentan—EDNRB—GPCR downstream signaling—AKT1—atherosclerosis	1.37e-05	0.000197	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—GPX1—atherosclerosis	1.37e-05	0.000197	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—IL6—atherosclerosis	1.35e-05	0.000194	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.34e-05	0.000193	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CD36—atherosclerosis	1.34e-05	0.000192	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—MAPK3—atherosclerosis	1.32e-05	0.000189	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.31e-05	0.000187	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—INS—atherosclerosis	1.31e-05	0.000187	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CCL2—atherosclerosis	1.29e-05	0.000184	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MMP9—atherosclerosis	1.28e-05	0.000184	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.28e-05	0.000183	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—NFKB1—atherosclerosis	1.27e-05	0.000182	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—MTHFR—atherosclerosis	1.27e-05	0.000181	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IGF1—atherosclerosis	1.26e-05	0.000181	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK8—atherosclerosis	1.25e-05	0.000179	CbGpPWpGaD
Bosentan—EDNRB—Signaling by GPCR—AKT1—atherosclerosis	1.25e-05	0.000179	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARA—atherosclerosis	1.24e-05	0.000178	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLTP—atherosclerosis	1.23e-05	0.000176	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AGT—atherosclerosis	1.2e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LCAT—atherosclerosis	1.2e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—FABP4—atherosclerosis	1.2e-05	0.000172	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—SERPINE1—atherosclerosis	1.2e-05	0.000172	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA4—atherosclerosis	1.18e-05	0.000169	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOE—atherosclerosis	1.18e-05	0.000169	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—CAV1—atherosclerosis	1.17e-05	0.000167	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—APOA1—atherosclerosis	1.17e-05	0.000167	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.16e-05	0.000166	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—VEGFA—atherosclerosis	1.15e-05	0.000165	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NOS3—atherosclerosis	1.15e-05	0.000164	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—STAT3—atherosclerosis	1.14e-05	0.000164	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.1e-05	0.000158	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—MAPK3—atherosclerosis	1.09e-05	0.000156	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.07e-05	0.000154	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.07e-05	0.000153	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.07e-05	0.000153	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PIK3CG—atherosclerosis	1.06e-05	0.000152	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—TGFB1—atherosclerosis	1.06e-05	0.000152	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.05e-05	0.000151	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.03e-05	0.000147	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PPARG—atherosclerosis	1.03e-05	0.000147	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—CXCL8—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA2—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.02e-05	0.000146	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—INS—atherosclerosis	1.01e-05	0.000144	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCG5—atherosclerosis	1e-05	0.000144	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1e-05	0.000144	CbGpPWpGaD
Bosentan—EDNRA—GPCR downstream signaling—AKT1—atherosclerosis	9.82e-06	0.000141	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPA—atherosclerosis	9.68e-06	0.000139	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—IL6—atherosclerosis	9.66e-06	0.000139	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—BGN—atherosclerosis	9.38e-06	0.000134	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.31e-06	0.000133	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA5—atherosclerosis	9.28e-06	0.000133	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—ALB—atherosclerosis	9.23e-06	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MMP9—atherosclerosis	9.19e-06	0.000132	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—NFKB1—atherosclerosis	9.09e-06	0.00013	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.02e-06	0.000129	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK8—atherosclerosis	8.94e-06	0.000128	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	8.94e-06	0.000128	CbGpPWpGaD
Bosentan—EDNRA—Signaling by GPCR—AKT1—atherosclerosis	8.92e-06	0.000128	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.84e-06	0.000127	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—NOS3—atherosclerosis	8.83e-06	0.000127	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.75e-06	0.000126	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.73e-06	0.000125	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALOX5—atherosclerosis	8.63e-06	0.000124	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.43e-06	0.000121	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—VEGFA—atherosclerosis	8.25e-06	0.000118	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—STAT3—atherosclerosis	8.17e-06	0.000117	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—PTGS2—atherosclerosis	8.08e-06	0.000116	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—IL6—atherosclerosis	7.98e-06	0.000114	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.97e-06	0.000114	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LCAT—atherosclerosis	7.92e-06	0.000114	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—FABP4—atherosclerosis	7.92e-06	0.000114	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—MAPK3—atherosclerosis	7.81e-06	0.000112	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA4—atherosclerosis	7.78e-06	0.000111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.74e-06	0.000111	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.7e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LIPC—atherosclerosis	7.69e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOC3—atherosclerosis	7.65e-06	0.00011	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.64e-06	0.00011	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LDLR—atherosclerosis	7.6e-06	0.000109	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—TGFB1—atherosclerosis	7.58e-06	0.000109	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CETP—atherosclerosis	7.42e-06	0.000106	CbGpPWpGaD
Bosentan—EDNRB—Signaling Pathways—AKT1—atherosclerosis	7.36e-06	0.000105	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.11e-06	0.000102	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.06e-06	0.000101	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.92e-06	9.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.71e-06	9.62e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.69e-06	9.6e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.69e-06	9.6e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA2—atherosclerosis	6.69e-06	9.6e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.69e-06	9.6e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.61e-06	9.48e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPA—atherosclerosis	6.39e-06	9.16e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—BGN—atherosclerosis	6.19e-06	8.87e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA5—atherosclerosis	6.12e-06	8.78e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.05e-06	8.68e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.98e-06	8.58e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.89e-06	8.45e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—IL6—atherosclerosis	5.71e-06	8.18e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.69e-06	8.16e-05	CbGpPWpGaD
Bosentan—EDNRA—Signaling Pathways—AKT1—atherosclerosis	5.27e-06	7.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.13e-06	7.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.11e-06	7.32e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LIPC—atherosclerosis	5.07e-06	7.27e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOC3—atherosclerosis	5.04e-06	7.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LDLR—atherosclerosis	5.01e-06	7.18e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOB—atherosclerosis	4.92e-06	7.05e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CETP—atherosclerosis	4.89e-06	7.02e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.78e-06	6.86e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—LPL—atherosclerosis	4.69e-06	6.73e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.69e-06	6.72e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—GPX1—atherosclerosis	4.58e-06	6.57e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CD36—atherosclerosis	4.46e-06	6.39e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.43e-06	6.35e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.23e-06	6.06e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARA—atherosclerosis	4.15e-06	5.94e-05	CbGpPWpGaD
Bosentan—ABCB11—Metabolism—AKT1—atherosclerosis	4.06e-06	5.82e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AGT—atherosclerosis	4.02e-06	5.76e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.95e-06	5.66e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOE—atherosclerosis	3.93e-06	5.64e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—CAV1—atherosclerosis	3.9e-06	5.59e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—APOA1—atherosclerosis	3.89e-06	5.58e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.55e-06	5.09e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PPARG—atherosclerosis	3.43e-06	4.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.39e-06	4.85e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—INS—atherosclerosis	3.36e-06	4.82e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOB—atherosclerosis	3.24e-06	4.65e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.15e-06	4.52e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—LPL—atherosclerosis	3.1e-06	4.44e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—ALB—atherosclerosis	3.08e-06	4.42e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—GPX1—atherosclerosis	3.02e-06	4.33e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—NOS3—atherosclerosis	2.95e-06	4.23e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CD36—atherosclerosis	2.94e-06	4.22e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.79e-06	4e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARA—atherosclerosis	2.73e-06	3.92e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.7e-06	3.87e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AGT—atherosclerosis	2.65e-06	3.8e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOE—atherosclerosis	2.6e-06	3.72e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—CAV1—atherosclerosis	2.57e-06	3.69e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—APOA1—atherosclerosis	2.57e-06	3.68e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.34e-06	3.36e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PPARG—atherosclerosis	2.26e-06	3.24e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—INS—atherosclerosis	2.22e-06	3.18e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—ALB—atherosclerosis	2.03e-06	2.91e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—NOS3—atherosclerosis	1.94e-06	2.79e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.78e-06	2.55e-05	CbGpPWpGaD
Bosentan—CYP2C9—Metabolism—AKT1—atherosclerosis	1.36e-06	1.94e-05	CbGpPWpGaD
Bosentan—CYP3A4—Metabolism—AKT1—atherosclerosis	8.94e-07	1.28e-05	CbGpPWpGaD
